Loading...

FITC anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2
C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
  • 17A2
    C57BL/6 splenocytes stained with 17A2 FITC and 145-2C11 PE
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100203 50 µg $36
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100204 500 µg $143
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References

(PubMed link indicates BioLegend citation)
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  2. Jiang W, et al. 2017. Sci Rep. 7:6501. PubMed
  3. Harsha Krovi S, et al. 2020. Nat Commun. 4.790277778. PubMed
  4. Dai L, et al. 2020. Cell. 182(3):722-733.e11. PubMed
  5. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  6. Zaman R, et al. 2021. Immunity. :. PubMed
  7. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  8. Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
  9. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  10. Lee JH, et al. 2022. EBioMedicine. 77:103903. PubMed
  11. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  12. Harel M, et al. 2020. J Immunol. 205:1167. PubMed
  13. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  14. Pei J, et al. 2022. J Virol. 96:e0194221. PubMed
  15. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  16. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  17. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  18. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  19. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  20. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  21. Shen CY, et al. 2022. Pharmaceutics. 14: . PubMed
  22. Brigo N, et al. 2022. Bio Protoc. 12:e4440. PubMed
  23. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  24. Mugarza E, et al. 2022. Sci Adv. 8:eabm8780. PubMed
  25. Xie DH, et al. 2022. Med Phys. 49:6728. PubMed
  26. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  27. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  28. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  29. Wei M, et al. 2022. Front Immunol. 13:1017574. PubMed
  30. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  31. You Q, et al. 2023. Adv Mater. 35:e2204910. PubMed
  32. Kim HI, et al. 2022. Molecules. 27: . PubMed
  33. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  34. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  35. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  36. Schepers M, et al. 2023. Brain Behav Immun. 109:1. PubMed
  37. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  38. Peng Q, et al. 2023. EMBO Rep. 24:e56034. PubMed
  39. Jin SM, et al. 2023. Nat Nanotechnol. :. PubMed
  40. Liu H, et al. 2023. Cell Death Differ. :. PubMed
  41. Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed
  42. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  43. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  44. Zhang W, et al. 2022. Dev Cell. 57:329. PubMed
  45. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  46. Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed
  47. Zimmerman SM, et al. 2022. Oncogene. 41:4983. PubMed
  48. Peng J, et al. 2023. Am J Reprod Immunol. 89:e13678. PubMed
  49. Chen H, et al. 2023. Nat Commun. 14:941. PubMed
  50. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  51. Liu HJ, et al. 2023. Nat Commun. 14:1214. PubMed
  52. Guo D, et al. 2023. Cell Biosci. 13:51. PubMed
  53. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  54. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  55. Sambandam A, et al. 2023. Heliyon. 9:e14238. PubMed
  56. Masle-Farquhar E, et al. 2023. Front Immunol. 14:1095257. PubMed
  57. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  58. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  59. Zhang YN, et al. 2023. Nat Commun. 14:1985. PubMed
  60. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  61. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  62. Kuang C, et al. 2023. Nat Commun. 14:2093. PubMed
  63. Zuo B, et al. 2023. Clin Transl Oncol. . PubMed
  64. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  65. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  66. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  67. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  68. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  69. Zeng S, et al. 2023. Front Oncol. 13:1171926. PubMed
  70. Lan Y, et al. 2023. iScience. 26:106817. PubMed
  71. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  72. Liu, C., Guo, J., et al. 2025. Stroke Vasc Neurol. 10(5),582-593. PubMed
  73. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  74. Gawish R, et al. 2022. Elife. 11:. PubMed
  75. Qiao Y, et al. 2021. Oncoimmunology. 10:1947569. PubMed
  76. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  77. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  78. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  79. Wilhelm J, et al. 2021. J Control Release. 329:353. PubMed
  80. Ford K, et al. 2020. Cancer Res. 80:1846. PubMed
  81. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  82. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  83. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  84. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  85. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  86. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  87. Wu X, et al. 2012. Biochem Pharmacol. 84:1164. PubMed
  88. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  89. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  90. Song C, et al. 2019. Nat Commun. 10:3745. PubMed
  91. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  92. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  93. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  94. Bao H, et al. 2020. Mol Med Rep. 4.675. PubMed
  95. Turner JA, et al. 2020. Immunity. 53:1202. PubMed
  96. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  97. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  98. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  99. Zhang S, et al. 2022. Acta Pharm Sin B. 12:3124. PubMed
  100. Steubing RD, et al. 2022. Brain Behav Immun Health. 24:100493. PubMed
  101. Mei S, et al. 2022. Front Immunol. 13:911164. PubMed
  102. Lu H, et al. 2021. Autophagy. 17:2511. PubMed
  103. Diao L, et al. 2022. iScience. 25:105511. PubMed
  104. Bangs DJ, et al. 2022. Cell Rep. 38:110266. PubMed
  105. Huang Y, et al. 2021. Radiother Oncol. 162:34. PubMed
  106. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  107. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  108. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  109. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  110. Liu Q, et al. 2021. Cell Death Dis. 12:240. PubMed
  111. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  112. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  113. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  114. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  115. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  116. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  117. Lesmeister M, et al. 2005. Reprod Biol Endocrinol. 29:74. PubMed
  118. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
  119. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  120. Mostafavi H, et al. 2022. PLoS Pathog. 18:e1010185. PubMed
  121. Sala D, et al. 2022. Mol Ther Methods Clin Dev. 25:170. PubMed
  122. Deng P, et al. 2022. Cells. 11:. PubMed
  123. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  124. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  125. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  126. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  127. Perner C, et al. 2020. Immunity. 53(5):1063-1077.e7. PubMed
  128. White C, et al. 2014. J Immunol. 193:5933. PubMed
  129. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  130. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  131. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  132. Solanki A, et al. 2018. Development. 145. PubMed
  133. Shields BD, et al. 2019. Cancer Res. 79:1113. PubMed
  134. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  135. Mingozzi F, et al. 2016. EMBO Mol Med. 8: 1039 - 1051. PubMed
  136. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  137. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  138. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  139. Carr RM, et al. 2021. Nat Commun. 12:2901. PubMed
  140. Pervaiz N, et al. 2021. Pigment Cell Melanoma Res. 34:918. PubMed
  141. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  142. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  143. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  144. Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
  145. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  146. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
  147. Wang X, et al. 2018. Mol Med Rep. 17:1660. PubMed
  148. Lee JS et al. 2018. Cell. 174(6):1559-1570 . PubMed
  149. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  150. Chen Q, et al. 2016. Nat Commun. 7:13193. PubMed
  151. Bogie JF, et al. 2020. Ther Adv Chronic Dis. 11:2040622320947378. PubMed
  152. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  153. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  154. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  155. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  156. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  157. Jie X, et al. 2022. J Immunother Cancer. 10:. PubMed
  158. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  159. Tang X, et al. 2022. Cell Rep. 41:111673. PubMed
  160. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  161. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  162. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  163. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  164. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  165. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  166. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  167. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  168. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  169. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  170. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  171. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  172. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  173. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  174. Akhter N, et al. 2016. J Biol Chem. 291: 23672 - 23680. PubMed
  175. Huang B, et al. 2015. PLoS One. 10: 0134715. PubMed
  176. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  177. Sreekumar PG, et al. 2018. J Control Release. 283:94. PubMed
  178. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  179. Li W, et al. 2019. Nat Commun. 10:3349. PubMed
  180. Xu X, et al. 2018. Cell. 175:1336. PubMed
  181. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  182. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  183. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  184. Ren W, et al. 2018. Mucosal Immunol. 12:531. PubMed
  185. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  186. Weinheimer-Haus E, et al. 2014. PLoS One. 9:91355. PubMed
  187. Zheng L, et al. 2020. Front Oncol. 10:531131. PubMed
  188. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  189. Liu W, et al. 2021. Cell Death Discov. 7:136. PubMed
  190. França TT, et al. 2021. JCI Insight. 6:. PubMed
  191. Carbone C, et al. 2021. J Immunother Cancer. 9:. PubMed
  192. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  193. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  194. Yang Z, et al. 2021. Onco Targets Ther. 14:4239. PubMed
  195. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  196. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  197. Port JR, et al. 2020. J Virol. 94:. PubMed
  198. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  199. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  200. Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed
  201. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  202. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  203. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  204. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  205. Ma W, et al. 2017. Cell Death & Disease. 10.1038/cddis.2017.47. PubMed
  206. Zhang W, et al. 2019. Mar Drugs. 0.845138889. PubMed
  207. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  208. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  209. Yu H, et al. 2021. Front Oncol. 11:736882. PubMed
  210. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  211. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  212. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  213. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  214. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  215. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
  216. Yi H, et al. 2021. Front Immunol. 12:719189. PubMed
  217. Qi J, et al. 2021. Nat Commun. 12:4755. PubMed
  218. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  219. Zhang YN, et al. 2021. Sci Adv. 7:eabj3107. PubMed
  220. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  221. Robertson TF, et al. 2021. J Cell Biol. 220:. PubMed
  222. Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed
  223. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  224. Wang Z, et al. 2021. Acta Pharm Sin B. 694:11. PubMed
  225. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  226. Wu L, et al. 2020. Cell Rep. 33:108327. PubMed
  227. Zan H, et al. 2017. Nat Commun. 8:14244. PubMed
  228. Cabrera-Perez J, et al. 2016. J Immunol. 197: 1692 - 1698. PubMed
  229. Kang J, Lee J, Chang J 2016. PLoS One. 11: 0157015. PubMed
  230. Cabrera-Perez C, et al. 2015. J Immunol . 194:1609-20. PubMed
  231. He J, et al. 2020. Evid Based Complement Alternat Med. 2020:5637507. PubMed
  232. Roy S, et al. 2019. Front Immunol. 2.404166667. PubMed
  233. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  234. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  235. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  236. Smith-Díaz CC, et al. 2021. Front Oncol. 11:709543. PubMed
  237. Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed
  238. Wang J, et al. 2022. Clin Transl Med. 12:e718. PubMed
  239. Lai Y, et al. 2022. Clin Transl Med. 12:e999. PubMed
  240. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  241. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  242. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  243. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  244. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  245. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  246. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  247. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  248. van den Berk P, et al. 2020. Cell Rep. 33:108533. PubMed
  249. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  250. Campolo M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  251. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  252. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  253. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  254. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  255. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  256. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  257. Zheng DW, et al. 2020. Nat Commun. 3.865972222. PubMed
  258. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  259. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  260. Fujimoto M, et al. 2022. Nat Commun. 13:5408. PubMed
  261. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  262. Ravindran Menon D, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  263. Le QV, et al. 2022. Bioact Mater. 15:160. PubMed
  264. Aulova KS, et al. 2022. Molecules. 27:. PubMed
  265. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  266. Tao Z, et al. 2022. Cells. 11:. PubMed
  267. Tang T, et al. 2022. J Immunother Cancer. 10:. PubMed
  268. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  269. Chen LH, et al. 2021. Sci Rep. 11:19478. PubMed
  270. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  271. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  272. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  273. Guo X, et al. 2020. J Cell Mol Med. . PubMed
  274. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  275. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  276. Pan X, et al. 2019. BMC Complement Altern Med. 19:163. PubMed
  277. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  278. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  279. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  280. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  281. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  282. Tur J, et al. 2020. Cell Reports. 32(8):108079. PubMed
  283. Roberto MP, et al. 2021. Immunity. 54(8):1807-1824.e14. PubMed
  284. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  285. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  286. Zheng Y, et al. 2022. Transl Res. :. PubMed
  287. Gawish R, et al. 2022. Elife. 11:. PubMed
  288. Li J, et al. 2022. Nat Commun. 13:1481. PubMed
  289. Sun Q, et al. 2022. J Inflamm Res. 15:5827. PubMed
  290. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  291. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  292. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  293. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  294. Erens C, et al. 2022. Biomedicines. 10:. PubMed
  295. Zhang J, et al. 2021. Stem Cell Res Ther. 12:579. PubMed
  296. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  297. Zuo S, et al. 2021. EBioMedicine. 64:103240. PubMed
  298. Zheng QY, et al. 2020. FASEB J. 34:10590. PubMed
  299. Li J, et al. 2021. eLife. 10:00. PubMed
  300. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  301. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
  302. Fan X, et al. 2014. PLoS One. 9:107638. PubMed
  303. Martínez-Vicente P, et al. 2019. PLoS Pathog. 15:e1007658. PubMed
  304. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  305. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
RRID
AB_312660 (BioLegend Cat. No. 100203)
AB_312661 (BioLegend Cat. No. 100204)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account